Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cyclovirobuxine D protects against diabetic cardiomyopathy by activating Nrf2-mediated antioxidant responses
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-14
DOI
10.1038/s41598-020-63498-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mitoquinone ameliorates pressure overload-induced cardiac fibrosis and left ventricular dysfunction in mice
- (2019) Kah Yong Goh et al. Redox Biology
- Trimetazidine prevents diabetic cardiomyopathy by inhibiting Nox2/TRPC3-induced oxidative stress
- (2019) Sheng-Gao Tang et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Obeticholic acid protects against diabetic cardiomyopathy by activation of FXR/Nrf2 signaling in db/db mice
- (2019) Hongkui Wu et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Current Status and Challenges of NRF2 as a Potential Therapeutic Target for Diabetic Cardiomyopathy
- (2019) Zhi-Dong Ge et al. International Heart Journal
- Mitophagy Reduces Oxidative Stress Via Keap1 (Kelch-Like Epichlorohydrin-Associated Protein 1)/Nrf2 (Nuclear Factor-E2-Related Factor 2)/PHB2 (Prohibitin 2) Pathway After Subarachnoid Hemorrhage in Rats
- (2019) Tongyu Zhang et al. STROKE
- Bardoxolone ameliorates TGF-β1-associated renal fibrosis through Nrf2/Smad7 elevation
- (2019) Min-Kyun Song et al. FREE RADICAL BIOLOGY AND MEDICINE
- A Novel Circular RNA Mediates Pyroptosis of Diabetic Cardiomyopathy by Functioning as a Competing Endogenous RNA
- (2019) Fan Yang et al. Molecular Therapy-Nucleic Acids
- The mitochondria-targeted antioxidant MitoQ inhibits memory loss, neuropathology, and extends lifespan in aged 3xTg-AD mice
- (2019) Melissa L. Young et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Therapeutic Effects of Nrf2 Activation by Bardoxolone Methyl in Chronic Heart Failure
- (2019) Changhai Tian et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Hydrogen peroxide depolarizes mitochondria and inhibits IP3-evoked Ca2+ release in the endothelium of intact arteries
- (2019) Xun Zhang et al. CELL CALCIUM
- Protective effects of sulforaphane on type 2 diabetes-induced cardiomyopathy via AMPK-mediated activation of lipid metabolic pathways and NRF2 function
- (2019) Yike Sun et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- M1/M2 macrophages in diabetic nephropathy: Nrf2/HO-1 as therapeutic targets
- (2018) R. Clive Landis et al. CURRENT PHARMACEUTICAL DESIGN
- Heart failure with preserved ejection fraction: from mechanisms to therapies
- (2018) Carolyn S P Lam et al. EUROPEAN HEART JOURNAL
- Gypenosides improve diabetic cardiomyopathy by inhibiting ROS-mediated NLRP3 inflammasome activation
- (2018) Hailong Zhang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Non-covalent Small-Molecule Kelch-like ECH-Associated Protein 1–Nuclear Factor Erythroid 2-Related Factor 2 (Keap1–Nrf2) Inhibitors and Their Potential for Targeting Central Nervous System Diseases
- (2018) Jakob S. Pallesen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Nrf2 at the heart of oxidative stress and cardiac protection
- (2018) Qin M. Chen et al. PHYSIOLOGICAL GENOMICS
- Facilitated Ca2+ homeostasis and attenuated myocardial autophagy contribute to alleviation of diabetic cardiomyopathy after bariatric surgery
- (2018) Xin Huang et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1
- (2018) Evanna L. Mills et al. NATURE
- Risk Factors, Mortality, and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2018) Aidin Rawshani et al. NEW ENGLAND JOURNAL OF MEDICINE
- Reactive oxygen species signalling in the diabetic heart: emerging prospect for therapeutic targeting
- (2017) Adam J Wilson et al. HEART
- Stress-sensing mechanisms and the physiological roles of the Keap1–Nrf2 system during cellular stress
- (2017) Takafumi Suzuki et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Small molecules inhibiting Keap1–Nrf2 protein–protein interactions: a novel approach to activate Nrf2 function
- (2017) Chunlin Zhuang et al. MedChemComm
- Salusin-β contributes to oxidative stress and inflammation in diabetic cardiomyopathy
- (2017) Ming-Xia Zhao et al. Cell Death & Disease
- Cyclovirobuxinum D alleviates cardiac hypertrophy in hyperthyroid rats by preventing apoptosis of cardiac cells and inhibiting the p38 mitogen-activated protein kinase signaling pathway
- (2016) Jun-biao Wu et al. Chinese Journal of Integrative Medicine
- Clinical Update: Cardiovascular Disease in Diabetes Mellitus
- (2016) Cecilia C. Low Wang et al. CIRCULATION
- Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care
- (2016) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care
- (2016) Julia Hippisley-Cox et al. BMJ-British Medical Journal
- Cyclovirobuxine D Attenuates Doxorubicin-Induced Cardiomyopathy by Suppression of Oxidative Damage and Mitochondrial Biogenesis Impairment
- (2015) Qian Guo et al. Oxidative Medicine and Cellular Longevity
- Updating Experimental Models of Diabetic Cardiomyopathy
- (2015) J. Fuentes-Antrás et al. Journal of Diabetes Research
- Cyclovirobuxine D Induces Autophagy-Associated Cell Death via the Akt/mTOR Pathway in MCF-7 Human Breast Cancer Cells
- (2014) Jing Lu et al. JOURNAL OF PHARMACOLOGICAL SCIENCES
- Enrichment of neonatal rat cardiomyocytes in primary culture facilitates long-term maintenance of contractility in vitro
- (2012) Phong D. Nguyen et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Beneficial effect of Cyclovirobuxine D on heart failure rats following myocardial infarction
- (2011) Bin Yu et al. FITOTERAPIA
- Managing the challenge of chemically reactive metabolites in drug development
- (2011) B. Kevin Park et al. NATURE REVIEWS DRUG DISCOVERY
- The Nrf2 System as a Potential Target for the Development of Indirect Antioxidants
- (2010) Kyeong-Ah Jung et al. MOLECULES
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search